3/A

PRIMARY DOCUMENT

Company: LIGAND PHARMACEUTICALS INC
Filed: February 13, 2012
Period of Report: February 9, 2012
Accession Number: 0000886163-12-000019

View Document ↗ View on SEC.gov ↗